Arcturus Therapeutics Holdings Inc at Barclays Global Healthcare Conference Transcript
Okay. Thank you. Good afternoon, everyone. And welcome to Barclays Global Healthcare Conference. It is my great pleasure to introduce our next presenting company, Arcturus Therapeutics. With us today, we have both Joe Payne, President and Chief Executive Officer; and also Andy Sassine, Chief Financial Officer. With that, I will hand over to Joe to give introduction slides.
All right. Thank you, Gena. It's good to be with you. It's good to be at a face-to-face conference, it's been a while. And I'm happy to introduce Arcturus Therapeutics to you. First of all, I think it's helpful. It says on the introductory slide, but this is next-generation RNA medicine. So Arcturus is a messenger RNA vaccines and therapeutics company. So both vaccines and therapeutics. And the critical issue, we believe, for vaccines right now, is addressing the dose level, which we believe is too high for messenger RNA vaccines.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
